Lupin launches Ortho-Cyclen tablets in US

Drug major Lupin has launched generic version of contraceptives Ortho-Cyclen tablets after approval from the US health regulator.
In a BSE filing, Lupin said, "It has launched its Norgestimate and Ethinyl Estradiol tablets USP, 0.25 mg/0.035 mg having received approval from the United States Food and Drug Administration (FDA) earlier to market a generic version of Janssen Pharmaceuticals Inc's Ortho-Cyclen 28 tablets".
Lupin's Norgestimate and Ethinyl Estradiol tablets USP, 0.25 mg/0.035 mg are the AB rated generic equivalent of Janssen Pharmaceuticals Inc's Ortho-Cyclen 28 tablets (Norgestimate/Ethinyl Estradiol).
Quoting IMS MAT September 2016 data, Lupin said, Ortho-Cyclen 28 tablets had the US sales of USD 204 million.

Shares of Lupin were trading 0.81 per cent higher at Rs 1,494.50 apiece on BSE.